Long-term safety and erythroid response with luspatercept treatment in patients with β-thalassemia

Authors
Category Primary study
JournalTherapeutic Advances in Hematology
Year 2022
This article has no abstract
Epistemonikos ID: 978042c51d2b7f122e27ff1de360dd79545162fd
First added on: Feb 15, 2025